164 related articles for article (PubMed ID: 29928378)
21. Repressing PDCD4 activates JNK/ABCG2 pathway to induce chemoresistance to fluorouracil in colorectal cancer cells.
Hu L; Liang Y; Wu K; Wang C; Zhang T; Peng R; Zou F
Ann Transl Med; 2021 Jan; 9(2):114. PubMed ID: 33569416
[TBL] [Abstract][Full Text] [Related]
22. WNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy.
Jiang G; Lin J; Wang W; Sun M; Chen K; Wang F
Genet Test Mol Biomarkers; 2017 Feb; 21(2):74-79. PubMed ID: 28051879
[TBL] [Abstract][Full Text] [Related]
23. Syndecan-2, negatively regulated by miR-20b-5p, contributes to 5-fluorouracil resistance of colorectal cancer cells via the JNK/ERK signaling pathway.
Hua R; Zhang Y; Yan X; Tang D; Li X; Ni Q; Wang D; Zhu J
Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1547-1557. PubMed ID: 34596215
[TBL] [Abstract][Full Text] [Related]
24. Effects of hexahydrocurcumin in combination with 5-fluorouracil on dimethylhydrazine-induced colon cancer in rats.
Srimuangwong K; Tocharus C; Tocharus J; Suksamrarn A; Chintana PY
World J Gastroenterol; 2012 Dec; 18(47):6951-9. PubMed ID: 23322993
[TBL] [Abstract][Full Text] [Related]
25. Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation.
Xavier CP; Lima CF; Rohde M; Pereira-Wilson C
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1449-57. PubMed ID: 21479885
[TBL] [Abstract][Full Text] [Related]
26. Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells.
Kodach LL; Bos CL; Durán N; Peppelenbosch MP; Ferreira CV; Hardwick JC
Carcinogenesis; 2006 Mar; 27(3):508-16. PubMed ID: 16344270
[TBL] [Abstract][Full Text] [Related]
27. Epigenetically Down-Regulated Acetyltransferase PCAF Increases the Resistance of Colorectal Cancer to 5-Fluorouracil.
Liu T; Wang X; Hu W; Fang Z; Jin Y; Fang X; Miao QR
Neoplasia; 2019 Jun; 21(6):557-570. PubMed ID: 31042625
[TBL] [Abstract][Full Text] [Related]
28. The combined anti-tumor effects of 5-fluorouracil and neurokinin receptor inhibitor, aprepitant, against colorectal cancer: In vitro and in vivo study.
Alalikhan A; Ebrahimi S; Aliee A; Mirzavi F; Hashemy SI
Med Oncol; 2024 Feb; 41(3):70. PubMed ID: 38340190
[TBL] [Abstract][Full Text] [Related]
29. Calbindin 2 (CALB2) regulates 5-fluorouracil sensitivity in colorectal cancer by modulating the intrinsic apoptotic pathway.
Stevenson L; Allen WL; Proutski I; Stewart G; Johnston L; McCloskey K; Wilson PM; Longley DB; Johnston PG
PLoS One; 2011; 6(5):e20276. PubMed ID: 21629658
[TBL] [Abstract][Full Text] [Related]
30. Resveratrol Modulates Chemosensitisation to 5-FU via β1-Integrin/HIF-1α Axis in CRC Tumor Microenvironment.
Brockmueller A; Girisa S; Kunnumakkara AB; Shakibaei M
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902421
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
[TBL] [Abstract][Full Text] [Related]
32. Effect of hypoxia on HIF
Wang L; Xing W; Qi J; Lu Y; Xiang L; Zhou Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1629-1636. PubMed ID: 36748372
[TBL] [Abstract][Full Text] [Related]
33. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
[TBL] [Abstract][Full Text] [Related]
34. The feedback loop of EFTUD2/c-MYC impedes chemotherapeutic efficacy by enhancing EFTUD2 transcription and stabilizing c-MYC protein in colorectal cancer.
Zhu X; Li C; Gao Y; Zhang Q; Wang T; Zhou H; Bu F; Chen J; Mao X; He Y; Wu K; Li N; Luo H
J Exp Clin Cancer Res; 2024 Jan; 43(1):7. PubMed ID: 38163859
[TBL] [Abstract][Full Text] [Related]
35. Icariin-mediated inhibition of NF-κB activity enhances the in vitro and in vivo antitumour effect of 5-fluorouracil in colorectal cancer.
Shi DB; Li XX; Zheng HT; Li DW; Cai GX; Peng JJ; Gu WL; Guan ZQ; Xu Y; Cai SJ
Cell Biochem Biophys; 2014 Jul; 69(3):523-30. PubMed ID: 24435883
[TBL] [Abstract][Full Text] [Related]
36. miR-34a increases the sensitivity of colorectal cancer cells to 5-fluorouracil
Zhang Q; Wang J; Li N; Liu Z; Chen Z; Li Z; Lai Y; Shen L; Gao J
Am J Cancer Res; 2018; 8(2):280-290. PubMed ID: 29511598
[TBL] [Abstract][Full Text] [Related]
37. Different effects of epigenetic modifiers on the cytotoxicity induced by 5-fluorouracil, irinotecan or oxaliplatin in colon cancer cells.
Ikehata M; Ogawa M; Yamada Y; Tanaka S; Ueda K; Iwakawa S
Biol Pharm Bull; 2014; 37(1):67-73. PubMed ID: 24172061
[TBL] [Abstract][Full Text] [Related]
38. Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells.
Paul S; Chatterjee S; Sinha S; Dash SR; Pradhan R; Das B; Goutam K; Kundu CN
Expert Opin Ther Targets; 2023; 27(10):999-1015. PubMed ID: 37787493
[TBL] [Abstract][Full Text] [Related]
39. N
Zhang K; Zhang T; Yang Y; Tu W; Huang H; Wang Y; Chen Y; Pan K; Chen Z
Theranostics; 2022; 12(10):4802-4817. PubMed ID: 35832094
[No Abstract] [Full Text] [Related]
40. HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy.
Nakamura J; Kitajima Y; Kai K; Hashiguchi K; Hiraki M; Noshiro H; Miyazaki K
Int J Cancer; 2010 Sep; 127(5):1158-71. PubMed ID: 20020496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]